Location History:
- Bellemeade, NJ (US) (1998)
- Somerville, NJ (US) (1999 - 2004)
- Belle Mead, NJ (US) (1998 - 2007)
- Hillsborough, NJ (US) (2002 - 2007)
- Belle Mead, PA (US) (2007)
Company Filing History:
6 out of 363 
2 out of 377 
2 out of 1,187 
Years Active: 1998-2007
Title: The Innovative Contributions of Linda K. Jolliffe
Introduction
Linda K. Jolliffe is a prominent inventor based in Hillsborough, NJ (US), known for her significant contributions to the field of biotechnology. With a remarkable portfolio of 15 patents, she has made strides in developing therapeutic solutions that address critical health issues.
Latest Patents
Among her latest patents, Jolliffe has developed small molecule mimetics of erythropoietin. This invention features computer-assisted methods for identifying molecules that bind to the EPO receptor and act as erythropoietin (EPO) mimetics. The preferred EPO mimetics identified using her method act as agonists of the EPO receptor in various in vitro or in vivo biological assays of EPO activity. Additionally, she has patented neuroprotective peptides, which involve methods of treating diseases of the nervous system through compositions that possess the neurological therapeutic activity of human erythropoietin. These compositions include therapeutic agents such as peptides, peptide dimers, polypeptides, and proteins that exhibit the full range of biological activity of human erythropoietin or specific biological activities of erythropoietin.
Career Highlights
Throughout her career, Jolliffe has worked with notable companies, including Ortho-McNeil Pharmaceutical Corporation and Ortho Pharmaceutical Corporation. Her work has significantly impacted the development of innovative therapies in the pharmaceutical industry.
Collaborations
Some of her notable coworkers include Robert Allan Zivin and Linda Mulcahy, who have collaborated with her on various projects, contributing to her success in the field.
Conclusion
Linda K. Jolliffe's innovative work and dedication to biotechnology have led to significant advancements in therapeutic solutions. Her contributions continue to influence the industry and improve health outcomes for many individuals.